Barinthus Biotherapeutics
BRNS----
Barinthus Biotherapeutics (BRNS)
Barinthus Biotherapeutics plc, together with its subsidiaries, engages in the research, development, and commercialization of immunotherapies and vaccines in th...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
Barinthus Biotherapeutics Analyst Rating
View MoreForecast & Rating
Mar 13, 2026Price forecast
$5.50813.62%
Forecast & RatingStrong buy
2analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- Global Report · 13 hours ago
Beyond the Mega-Caps: AI Patent Wars, Housing Slowdowns, and the Market's Messy Middle
- Global Report · 2 days ago, 04:18 AM
Columbia Financial's USD 1.7B Raise and Timken's Guidance Hike Lead Mid-2026 Strategic Shifts
- Global Report · Jul 21 at 04:13 AM
Navigating the 2026 Market Fractures: The AI Infrastructure Boom Meets the Consumer Credit Squeeze
- benzinga_article · Jul 17 at 07:05 AM
12 Health Care Stocks Moving In Friday's Pre-Market Session
- PUBT · Jul 2 at 03:06 PM
Barinthus Biotherapeutics holds annual general meeting
- benzinga_article · Jun 8 at 07:06 AM
12 Health Care Stocks Moving In Monday's Pre-Market Session
